Maximizing Safety in the Conduct of Alzheimer’s Disease Fluid Biomarker Research in the Era of COVID-19

The coronavirus disease 2019 (COVID-19) pandemic led to an abrupt halt of many Alzheimer’s disease (AD) research studies at sites spanning the world. This is especially true for studies requiring in-person contact, such as studies collecting biofluids. Since COVID-19 is likely to remain a threat for...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Alzheimers Dis
Auteurs principaux: Schindler, Suzanne E., Jicha, Gregory A., Nelson, Peter T., Keene, C. Dirk, Blennow, Kaj, Molinuevo, José Luis, Masters, Colin L., Hansson, Oskar, Teunissen, Charlotte E., Galasko, Douglas, Shaw, Leslie M., Levey, Allan I., Silverberg, Nina
Format: Artigo
Langue:Inglês
Publié: 2020
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7995336/
https://ncbi.nlm.nih.gov/pubmed/32568212
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-200684
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires